A Collaboration with the University of Pittsburgh

Bill proposed to force FDA decision on Plan B status

[JURIST] In response to what has been described as the "slow pace" by which the Food and Drug Administration [official website] is acting to approve the so-called "morning after pill" for over-the-counter sale, a bipartisan group of US representatives on Thursday introduced a bill that would make the drug available [press release] without a prescription after 30 days of the bill's approval unless the FDA makes a decision on the drug. The US government has been engaged in a protracted political fight over the drug, also known as Plan B [product website; FDA backgrounder], and the FDA has been accused of political posturing in deciding the drug's status [JURIST report]. In August, a high level FDA official resigned from the agency [JURIST report], asserting that in delaying its decision to make the drug available over-the-counter, the FDA was ignoring its own scientific findings that concluded the drug was safe for adult women. The drug continues to be available with a doctor's prescription. Reuters has more.

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.